Skre H (1974) Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clin Genet 6:98–118
CAS
PubMed
Article
Google Scholar
Fridman V, Bundy B, Reilly MM, Pareyson D, Bacon C, Burns J, Day J, Feely S et al (2015) CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis. J Neurol Neurosurg Psychiatry 86:873–878
CAS
PubMed
Article
Google Scholar
Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke JM et al (2012) Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706–710
PubMed
Article
Google Scholar
Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF et al (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66:219–232
CAS
PubMed
Article
Google Scholar
Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, Ben Othman K, Cullen B et al (1992) The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet 1:171–175
CAS
PubMed
Article
Google Scholar
Hayasaka K, Ohnishi A, Takada G, Fukushima Y, Murai Y (1993) Mutation of the myelin P0 gene in Charcot-Marie-tooth neuropathy type 1. Biochem Biophys Res Commun 194:1317–1322
CAS
PubMed
Article
Google Scholar
Pareek S, Notterpek L, Snipes GJ, Naef R, Sossin W, Laliberte J, Iacampo S, Suter U et al (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 17:7754–7762
CAS
PubMed
PubMed Central
Article
Google Scholar
Anelli T, Sitia R (2008) Protein quality control in the early secretory pathway. EMBO J 27:315–327
CAS
PubMed
PubMed Central
Article
Google Scholar
Fortun J, Go JC, Li J, Amici SA, Dunn WA Jr, Notterpek L (2006) Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis 22:153–164
CAS
PubMed
Article
Google Scholar
Lee S, Bazick H, Chittoor-Vinod V, Al Salihi MO, Xia G, Notterpek L (2018) Elevated peripheral myelin protein 22, reduced mitotic potential, and proteasome impairment in dermal fibroblasts from Charcot-Marie-Tooth disease type 1A patients. Am J Pathol 188:728–738
CAS
PubMed
PubMed Central
Article
Google Scholar
Notterpek L, Ryan MC, Tobler AR, Shooter EM (1999) PMP22 accumulation in aggresomes: implications for CMT1A pathology. Neurobiol Dis 6:450–460
CAS
PubMed
Article
Google Scholar
Schlebach JP, Peng D, Kroncke BM, Mittendorf KF, Narayan M, Carter BD, Sanders CR (2013) Reversible folding of human peripheral myelin protein 22, a tetraspan membrane protein. Biochemistry 52:3229–3241
CAS
PubMed
Article
Google Scholar
Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D (2000) Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 5:897–904
CAS
PubMed
Article
Google Scholar
Lin JH, Li H, Zhang Y, Ron D, Walter P (2009) Divergent effects of PERK and IRE1 signaling on cell viability. PLoS One 4:e4170
PubMed
PubMed Central
Article
CAS
Google Scholar
Ha N, Choi YI, Jung N, Song JY, Bae DK, Kim MC, Lee YJ, Song H et al (2020) A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A. Br J Pharmacol 177:5096–5113
CAS
PubMed
PubMed Central
Article
Google Scholar
Okamoto Y, Pehlivan D, Wiszniewski W, Beck CR, Snipes GJ, Lupski JR, Khajavi M (2013) Curcumin facilitates a transitory cellular stress response in Trembler-J mice. Hum Mol Genet 22:4698–4705
CAS
PubMed
PubMed Central
Article
Google Scholar
Khajavi M, Shiga K, Wiszniewski W, He F, Shaw CA, Yan J, Wensel TG, Snipes GJ et al (2007) Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet 81:438–453
CAS
PubMed
PubMed Central
Article
Google Scholar
Sanmaneechai O, Feely S, Scherer SS, Herrmann DN, Burns J, Muntoni F, Li J, Siskind CE et al (2015) Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Brain 138:3180–3192
PubMed
PubMed Central
Article
Google Scholar
Grandis M, Vigo T, Passalacqua M, Jain M, Scazzola S, La Padula V, Brucal M, Benvenuto F et al (2008) Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations. Hum Mol Genet 17:1877–1889
CAS
PubMed
Article
Google Scholar
Bai Y, Wu X, Brennan KM, Wang DS, D’Antonio M, Moran J, Svaren J, Shy ME (2018) Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1B. Ann Clin Transl Neurol 5:445–455
CAS
PubMed
PubMed Central
Article
Google Scholar
Khajavi M, Inoue K, Wiszniewski W, Ohyama T, Snipes GJ, Lupski JR (2005) Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. Am J Hum Genet 77:841–850
CAS
PubMed
PubMed Central
Article
Google Scholar
Pennuto M, Tinelli E, Malaguti M, Del Carro U, D’Antonio M, Ron D, Quattrini A, Feltri ML et al (2008) Ablation of the UPR-Mediator CHOP Restores Motor Function and Reduces Demyelination in Charcot-Marie-Tooth 1B Mice. Neuron 57:393–405
CAS
PubMed
PubMed Central
Article
Google Scholar
Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, Tinelli E, Saveri P et al (2012) MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Brain 135:2032–2047
PubMed
PubMed Central
Article
Google Scholar
Das I, Krzyzosiak A, Schneider K, Wrabetz L, D’Antonio M, Barry N, Sigurdardottir A, Bertolotti A (2015) Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science 348:239–242. https://doi.org/10.1126/science.aaa4484
CAS
Article
PubMed
PubMed Central
Google Scholar
Fledrich R, Stassart RM, Sereda MW (2012) Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease. Br Med Bull 102:89–113
CAS
PubMed
Article
Google Scholar
Verhamme C, King RH, ten Asbroek AL, Muddle JR, Nourallah M, Wolterman R, Baas F, van Schaik IN (2011) Myelin and axon pathology in a long-term study of PMP22-overexpressing mice. J Neuropathol Exp Neurol 70:386–398
CAS
PubMed
Article
Google Scholar
Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM et al (2005) Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681–694
CAS
PubMed
PubMed Central
Article
Google Scholar
D’Antonio M, Musner N, Scapin C, Ungaro D, Del Carro U, Ron D, Feltri ML, Wrabetz L (2013) Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice. J Exp Med 210:821–838
CAS
PubMed
PubMed Central
Article
Google Scholar
Wrabetz L, D’Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D et al (2006) Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci 26:2358–2368
CAS
PubMed
PubMed Central
Article
Google Scholar
Takeo T, Nakagata N (2011) Reduced glutathione enhances fertility of frozen/thawed C57BL/6 mouse sperm after exposure to methyl-beta-cyclodextrin. Biol Reprod 85:1066–1072
CAS
PubMed
Article
Google Scholar
Biffi A, De Palma M, Quattrini A, Del Carro U, Amadio S, Visigalli I, Sessa M, Fasano S et al (2004) Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest 113:1118–1129
CAS
PubMed
PubMed Central
Article
Google Scholar
Lancaster E, Li J, Hanania T, Liem R, Scheideler MA, Scherer SS (2018) Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E. Exp Neurol 308:13–25
PubMed
Article
Google Scholar
Ferri C, Quattrini A, D’Antonio M (2018) Electron microscopy for the analysis of peripheral nerve myelin. Methods Mol Biol 1791:3–13
CAS
PubMed
Article
Google Scholar
Patzko A, Bai Y, Saporta MA, Katona I, Wu X, Vizzuso D, Feltri ML, Wang S et al (2012) Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain 135:3551–3566
PubMed
PubMed Central
Article
Google Scholar
Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D’Antonio M, Martini R, Yin X et al (2000) P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021–1034
CAS
PubMed
PubMed Central
Article
Google Scholar
D’Antonio M, Michalovich D, Paterson M, Droggiti A, Woodhoo A, Mirsky R, Jessen KR (2006) Gene profiling and bioinformatic analysis of Schwann cell embryonic development and myelination. Glia 53:501–515
PubMed
Article
Google Scholar
Parkinson DB, Bhaskaran A, Arthur-Farraj P, Noon LA, Woodhoo A, Lloyd AC, Feltri ML, Wrabetz L et al (2008) c-Jun is a negative regulator of myelination. J Cell Biol 181:625–637
CAS
PubMed
PubMed Central
Article
Google Scholar
Hantke J, Carty L, Wagstaff LJ, Turmaine M, Wilton DK, Quintes S, Koltzenburg M, Baas F et al (2014) c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy. Brain 137:2922–2937
PubMed
PubMed Central
Article
Google Scholar
Volpi VG, Touvier T, D’Antonio M (2017) Endoplasmic reticulum protein quality control failure in myelin disorders. Front Mol Neurosci 9:162
PubMed
PubMed Central
Article
CAS
Google Scholar
Bai Y, Ianokova E, Pu Q, Ghandour K, Levinson R, Martin JJ, Ceuterick-de Groote C et al (2006) Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes. Arch Neurol 63:1787–1794
PubMed
Article
Google Scholar
Miller LJ, Patzko A, Lewis RA, Shy ME (2012) Phenotypic presentation of the Ser63Del MPZ mutation. J Peripher Nerv Syst 17:197–200
CAS
PubMed
PubMed Central
Article
Google Scholar
Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA (1996) Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 17:435–449
CAS
PubMed
Article
Google Scholar
Avila RL, D’Antonio M, Bachi A, Inouye H, Feltri ML, Wrabetz L, Kirschner DA (2010) P0 (protein zero) mutation S34C underlies instability of internodal myelin in S63C mice. J Biol Chem 285:42001–42012
CAS
PubMed
PubMed Central
Article
Google Scholar
Monk KR, Feltri ML, Taveggia C (2015) New insights on Schwann cell development. Glia 63:1376–1393
PubMed
PubMed Central
Article
Google Scholar
Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468:244–252
CAS
PubMed
Article
Google Scholar
Greenfield S, Brostoff S, Eylar EH, Morell P (1973) Protein composition of myelin of the peripheral nervous system. J Neurochem 20:1207–1216
CAS
PubMed
Article
Google Scholar
Lemke G, Axel R (1985) Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40:501–508
CAS
PubMed
Article
Google Scholar
Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4:181–191
CAS
PubMed
Article
Google Scholar
VerPlank JJS, Lokireddy S, Feltri ML, Goldberg AL, Wrabetz L (2018) Impairment of protein degradation and proteasome function in hereditary neuropathies. Glia 66:379–395
PubMed
Article
Google Scholar
Volpi VG, Ferri C, Fregno I, Del Carro U, Bianchi F, Scapin C, Pettinato E, Solda T et al (2019) Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice. PLoS Genet 15:e1008069
CAS
PubMed
PubMed Central
Article
Google Scholar
VerPlank JJS, Gawron J, Silvestri NJ, Feltri ML, Wrabetz L, Goldberg AL (2021) Raising cGMP restores proteasome function and myelination in mice with a proteotoxic neuropathy. Brain. https://doi.org/10.1093/brain/awab249
Article
Google Scholar
Florio F, Ferri C, Scapin C, Feltri ML, Wrabetz L, D’Antonio M (2018) Sustained expression of negative regulators of myelination protects Schwann cells from dysmyelination in a Charcot-Marie-Tooth 1B mouse model. J Neurosci 38:4275–4287
CAS
PubMed
PubMed Central
Article
Google Scholar
Howard P, Feely SME, Grider T, Bacha A, Scarlato M, Fazio R, Quattrini A, Shy ME et al (2021) Loss of Function MPZ Mutation causes milder CMT1B Neuropathy. J Peripher Nerv Syst 26:177–183
CAS
PubMed
Article
Google Scholar
Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5:563–569
CAS
PubMed
Article
Google Scholar
Sereda M, Griffiths I, Puhlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A et al (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16:1049–1060
CAS
PubMed
Article
Google Scholar
Pareek S, Suter U, Snipes GJ, Welcher AA, Shooter EM, Murphy RA (1993) Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem 268:10372–10379
CAS
PubMed
Article
Google Scholar
Marinko JT, Carter BD, Sanders CR (2020) Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22. J Biol Chem 295:11963–11970
CAS
PubMed
PubMed Central
Article
Google Scholar
Katona I, Wu X, Feely SM, Sottile S, Siskind CE, Miller LJ, Shy ME, Li J (2009) PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain 132:1734–1740
PubMed
PubMed Central
Article
Google Scholar
Li J, Bai Y, Ghandour K, Qin P, Grandis M, Trostinskaia A, Ianakova E, Wu X et al (2005) Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 128:1168–1177
PubMed
Article
Google Scholar
Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ (1997) Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 49:1635–1640
CAS
PubMed
Article
Google Scholar
Vallat JM, Sindou P, Preux PM, Tabaraud F, Milor AM, Couratier P, LeGuern E, Brice A (1996) Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 39:813–817
CAS
PubMed
Article
Google Scholar
Hirt N, Eggermann K, Hyrenbach S, Lambeck J, Busche A, Fischer J, Rudnik-Schoneborn S, Gaspar H (2015) Genetic dosage compensation via co-occurrence of PMP22 duplication and PMP22 deletion. Neurology 84:1605–1606
PubMed
Article
Google Scholar
Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D et al (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7:449–458
CAS
PubMed
Article
Google Scholar
Perea J, Robertson A, Tolmachova T, Muddle J, King RH, Ponsford S, Thomas PK, Huxley C (2001) Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 10:1007–1018
CAS
PubMed
Article
Google Scholar
Pantera H, Shy ME, Svaren J (2020) Regulating PMP22 expression as a dosage sensitive neuropathy gene. Brain Res 1726:146491. https://doi.org/10.1016/j.brainres.2019.146491
CAS
Article
PubMed
Google Scholar
Boutary S, Caillaud M, El Madani M, Vallat JM, Loisel-Duwattez J, Rouyer A, Richard L, Gracia C et al (2021) Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A. Commun Biol 4:317
CAS
PubMed
PubMed Central
Article
Google Scholar
Boutary S, Echaniz-Laguna A, Adams D, Loisel-Duwattez J, Schumacher M, Massaad C, Massaad-Massade L (2021) Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future. Trans Res 227:100–111
CAS
Article
Google Scholar
Gautier B, Hajjar H, Soares S, Berthelot J, Deck M, Abbou S, Campbell G, Ceprian M et al (2021) AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A. Nat Commun 12:2356
CAS
PubMed
PubMed Central
Article
Google Scholar
Zhao HT, Damle S, Ikeda-Lee K, Kuntz S, Li J, Mohan A, Kim A, Hung G et al (2018) PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models. J Clin Investig 128:359–368
PubMed
Article
Google Scholar
Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF et al (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 10:396–401
CAS
PubMed
Article
Google Scholar
Kimura J (2005) Nerve conduction and electromyography. In: Dyck PJ, Thomas PK (eds) Peripheral Neuropathy, 4th ed. Vol. 1. Elsevier/Saunders, Philadelphia, pp 899–970
Wu S, Stone S, Yue Y, Lin W (2021) Endoplasmic reticulum associated degradation is required for maintaining endoplasmic reticulum homeostasis and viability of mature Schwann cells in adults. Glia 69:489–506
CAS
PubMed
Article
Google Scholar
Chen Y, Kunjamma RB, Weiner M, Chan JR, Popko B (2021) Prolonging the integrated stress response enhances CNS remyelination in an inflammatory environment. Elife 10:e65469
CAS
PubMed
PubMed Central
Article
Google Scholar
Chen Y, Podojil JR, Kunjamma RB, Jones J, Weiner M, Lin W, Miller SD, Popko B (2019) Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis. Brain 142:344–361
PubMed
PubMed Central
Article
Google Scholar